Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats

Dries Testelmans, Karen Maes, Patrick Wouters, Nadège Gosselin, Keith Deruisseau, Scott Powers, Raf Sciot, Marc Decramer, Ghislaine Gayan-Ramirez

Research output: Contribution to journalArticle

72 Scopus citations

Abstract

OBJECTIVE: Nondepolarizing neuromuscular blocking agents are commonly used in the intensive care setting, but they have occasionally been associated with development of myopathy. In addition, diaphragmatic atrophy and a reduction in diaphragmatic force were reported after short-term controlled mechanical ventilation in animal models. We hypothesized that infusion of rocuronium, an aminosteroidal neuromuscular blocking agent, during 24 hrs of controlled mechanical ventilation would further alter diaphragm function and would enhance activation of the ubiquitin- proteasome pathway. DESIGN: Randomized, controlled experiment. SETTING: Basic animal science laboratory. SUBJECTS: Male Wistar rats, 14 wks old. INTERVENTIONS: Rats were divided into four groups: a control group, a group of anesthetized rats breathing spontaneously for 24 hrs, and two groups submitted to mechanical ventilation for 24 hrs, receiving a continuous infusion of either 0.9% NaCl or rocuronium. MEASUREMENTS AND MAIN RESULTS: In vitro diaphragm force was decreased more significantly after 24 hrs of mechanical ventilation combined with rocuronium infusion than after mechanical ventilation alone (e.g., tetanic force, -27%; p < .001 vs. mechanical ventilation). Similarly, the decrease in diaphragm type IIx/b fiber dimensions was more pronounced after mechanical ventilation with rocuronium treatment than with saline treatment (-38% and -29%, respectively; p < .001 vs. control). Diaphragm hydroperoxide levels increased similarly in both mechanically ventilated groups. Diaphragm muscle RING-finger protein-1 (MURF-1) messenger RNA expression, an E3 ligase of the ubiquitin-proteasome pathway, increased after mechanical ventilation (+212%, p < .001 vs. control) and increased further with combination of rocuronium (+320%, p < .001 vs. control). Significant correlations were found between expression of MURF-1 messenger RNA, diaphragm force, and type IIx/b fiber dimensions. CONCLUSIONS: Infusion of rocuronium during controlled mechanical ventilation leads to further deterioration of diaphragm function, additional atrophy of type IIx/b fibers, and an increase in MURF-1 messenger RNA in the diaphragm, which suggests an activation of the ubiquitin-proteasome pathway. These findings could be important with regard to weaning failure in patients receiving this drug for prolonged periods in the intensive care unit setting.

Original languageEnglish (US)
Pages (from-to)3018-3023
Number of pages6
JournalCritical Care Medicine
Volume34
Issue number12
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

Keywords

  • Mechanical ventilation
  • Muscle RING-finger protein-1
  • Neuromuscular blocking agents
  • Respiratory muscles

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats'. Together they form a unique fingerprint.

  • Cite this

    Testelmans, D., Maes, K., Wouters, P., Gosselin, N., Deruisseau, K., Powers, S., Sciot, R., Decramer, M., & Gayan-Ramirez, G. (2006). Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Critical Care Medicine, 34(12), 3018-3023. https://doi.org/10.1097/01.CCM.0000245783.28478.AD